Endoscopy Devices Global Market - Forecast To 2028
Endoscopy is a minimally invasive or non-invasive medical procedure that utilizes specialized devices like endoscopes for the detailed inspection or assessment, and manipulation or treatment of diseased organs or tissues by visualizing the internal organ or area of interest. The constantly advancing various emergency or elective endoscopy procedures are being used for the timely diagnosis, and minimally-traumatic treatment of various chronic ailments like cancer, arthritis, joint injuries, inflammatory bowel diseases (IBD), chronic pancreatitis, obesity, Barrett’s esophagus, and others.
As estimated by IQ4I analysis, the endoscopy devices global market is expected to reach $39,475.6 million by 2028 growing at a high single digit CAGR from 2021 to 2028 due to persistently escalating prevalence, and incidence of chronic diseases across the globe, and the need for early diagnostic, and therapeutic interventions, increasing inclination of patients towards the minimally invasive therapeutic procedures, gradual transition of endoscopy devices market towards single-use endoscopes, the emergence of technologically advanced endoscopy products, the trend of acquisitions, and collaborations in the endoscopy device industry, and the increasing awareness, and adoption of the highly beneficial endoscopic procedures across the emerging nations.
The endoscopy devices global market is categorized into various market segments based on the product, application, end-users, and geography. Based on the type of endoscopy products, the market is segmented into endoscopes, endoscopic instruments, and endoscopic accessories. Among these, the Endoscopic Instruments segment held the largest share in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the increasing popularity of image-guided endoscopic surveillance, diagnostic, and therapeutic procedures to reduce morbidity, and mortality associated with the highly prevalent chronic diseases across the globe, and the necessity of the various endoscopy instruments to ensure the efficiency, safety, and completeness of an endoscopy procedure. Endoscopes segment is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the escalating demand for timely, and precise minimally invasive or non-invasive diagnostic, and therapeutic procedures from the large chronic disease patient pool across the globe, various technological, and fabrication advancements in endoscopes that are constantly expanding their diagnostic, and therapeutic application spectrum. Based on the product type, endoscopes have been further segmented into flexible endoscopes, rigid endoscopes, robot-assisted endoscopes, and AI-enhanced endoscopes, and capsule endoscopes. Among these, the Rigid Endoscopes segment occupy a major share in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028 due to increased utilization of rigid endoscopes for performing the highly popular endoscopic diagnostic, and therapeutic procedures like laparoscopy, arthroscopy, ENT endoscopy, and neuroendoscopy procedures, and the potential of rigid endoscopes to offer the best resolution, optical amplification, and larger field of view to perform various endoscopic procedures efficiently, and safely. Robot-Assisted Endoscopes, and artificial intelligence (AI) powered endoscopes segment is expected to be the fastest emerging segment growing with a double digit CAGR from 2021 to 2028 due to the emergence of several Robot Assisted Endoscopes, and AI guided endoscopy systems in the market, and the promising potential of robot-assisted endoscopes, and AI-enhanced endoscopy systems to mitigate the labor intensity of endoscopic procedures, and increase the precision, and safety of endoscopic procedures. Endoscopic instruments are further grouped into endoscopic cameras, digital documentation systems, light sources, monitors, and display systems, video converters, and processors, fluid management systems, and other endoscopic instruments comprised of insufflators, endoscopic ultrasound probes, and processors. Among the various endoscopic instruments, the Monitors, and display systems segment occupies a major share of revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the increasing utilization of highly accurate, and real-time images or videos to arrive at the optimum or error-free diagnostic conclusions, and to provide better clarity of the complex anatomical details to improve the precision, task efficiency, and productivity of surgeons during endoscopic therapeutic procedures, availability of technologically advanced monitors, and display units, and increasing popularity of image-guided minimally invasive endoscopic diagnostic, and therapeutic interventions among the masses. The digital documentation systems segment is expected to be the fastest-growing segment growing with a high single digit CAGR from 2021 to 2028 due to the increasing recognition of the importance of endoscopic image documentation or recording process as an integral aspect of endoscopy procedures to ensure the quality, safety, productivity, completeness, and efficiency of endoscopic procedures, and the various guidelines of major endoscopic societies like European Society of Gastrointestinal Endoscopy (ESGE), and American Society of Gastrointestinal Endoscopy (ASGE) that recommend systematic photo recording or documentation of endoscopy procedures, the necessity of digitalized documents to address or satisfy the concerns of the insurance providers, legal institutions, patients, and hospital trusts, and need of digital documents to guide future therapeutic decisions, and persistent technological advancements in the digital documentation systems. Endoscopic accessories are further classified into product types like biopsy forceps, graspers, snares, Trocars, surgical dissectors, and other accessories like endoscopic ultrasound needles, light cables, cytology brushes, bite-blocks, cleaning brushes, needle holders, retractors, endoscopic caps, and hoods, endoscopy masks. Among the various endoscopic accessories, the trocars segment occupy the largest share of revenue in 2021, and is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the necessity of the channel created by a trocar for the safer advancement or passage of endoscopes, and other equipment to internal body cavities through the smaller incisions with low insertion force, and without tearing, scarring or ripping off the surrounding fragile tissues or organs during endoscopy procedures.
The global endoscopy devices market based on applications has been classified into Arthroscopy, Pulmonary endoscopy, Laparoscopy, ENT endoscopy, Gastrointestinal endoscopy, Gynecology or obstetrics endoscopy, Neuroendoscopy, Urological endoscopy, and other Endoscopic applications consisting of cardiopulmonary endoscopy, dental endoscopy, ophthalmology endoscopy, and breast endoscopy. Among these, the Gastrointestinal endoscopy segment occupied the largest market share in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the persistently increasing prevalence of chronic diseases of the digestive tract, and the potential of gastrointestinal endoscopy to provide accurate diagnostic, and therapeutic solutions, increasing popularity of endoscopic surveillance as a preventive strategy for gastrointestinal cancer-associated morbidity, and mortality, and the ever-expanding diagnostic, and therapeutic application spectrum of gastrointestinal endoscopy procedures. The laparoscopy segment is the fastest emerging segment growing at a double digit CAGR from 2021 to 2028 due to the steadily escalating prevalence of chronic diseases of the digestive system, female reproductive system, and urinary tract system, and the potential of laparoscopy to provide accurate diagnostic, and therapeutic solutions, and the increasing research, and development activities leading to the emergence of numerous technologically advanced, patient-friendly, cosmetically advantageous laparoscopic procedures. The arthroscopy market is further segmented into knee arthroscopy, shoulder arthroscopy, wrist arthroscopy, ankle arthroscopy, elbow arthroscopy, hip arthroscopy, and other arthroscopy procedures consisting of spinal arthroscopy, and temporomandibular joint arthroscopy. Among these, the knee arthroscopy segment accounted for the largest revenue in 2021, and is expected to grow at a double digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of knee joint injuries especially related to sports, and increasing adoption of arthroscopy to provide premium diagnostic, and accurate therapeutic solutions. The hip arthroscopy segment is the fastest emerging segment growing at a double digit CAGR during the forecasted period due to the ever-escalating prevalence of hip injuries associated with sports or accidents, increasing popularity of hip arthroscopy procedures across the globe, and the increasing research focus for the development of more efficient, and safer hip arthroscopy products. The pulmonary endoscopy market is further classified into bronchoscopy, thoracoscopy, and mediastinoscopy. Among these, the bronchoscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the persistently escalating prevalence of chronic diseases of the lungs or bronchi, increasing utilization of bronchoscopy to provide premium diagnostic, and accurate therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of bronchoscopy, and the increasing research focus for the development of more efficient, and safer bronchoscopy products. The ENT endoscopy market is further categorized into nasal endoscopy, laryngoscopy, otoendoscopy, and transnasal endoscopy procedures. Among these, the nasal endoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the constantly escalating prevalence of chronic diseases associated with nasal cavity, and sinus passages, and increasing adoption of nasal endoscopy to provide optimum diagnostic, and therapeutic solutions. The laryngoscopy segment is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the ever elevating prevalence of chronic diseases associated with throat, larynx, and salivary gland, increasing popularity of laryngoscopy procedures across the globe, and the increasing research focus for the development of more efficient, and laryngoscopy products. The gastrointestinal endoscopy market is further segmented into Esophagogastroduodenoscopy, enteroscopy, colonoscopy, sigmoidoscopy, proctoscopy, and Cholangiopancreatoscopy procedures. Among these, the esophagogastroduodenoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR during the forecasted period due to the persistently escalating chronic diseases affecting the esophagus, stomach, duodenum, increasing adoption of esophagogastroduodenoscopy to provide optimized, and timely diagnostic, and therapeutic solutions, and the emergence of more efficient, and safer technologically advanced esophagogastroduodenoscopy products. The colonoscopy segment is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the ever-increasing prevalence of chronic diseases of the colon, and rectum, increasing adoption, and implementation of colonoscopic surveillance as a preventive strategy for colorectal cancer-associated morbidity, and mortality across the globe, and the increasing research focus for the development of more efficient, and colonoscopy products. The gynecological/obstetrics endoscopy market is further classified into Hysteroscopy, Colposcopy, Falloposcopy, and others comprised of amnioscopy, and fetoscopy procedures. Among these, the hysteroscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the steadily escalating prevalence of endocervical or intrauterine diseases, increasing utilization of hysteroscopy to provide precise diagnostic, and therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of hysteroscopy, and the increasing research focus for the development of more efficient, and safer hysteroscopy products. The neuroendoscopy market is further subdivided into epiduroscopy or spinal endoscopy, Intraventricular neuroendoscopy, Transcranial neuroendoscopy, and Transnasal neuroendoscopy procedures. Among these, the intraventricular neuroendoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of ventricular system associated diseases, and increasing adoption of intraventricular neuroendoscopy to provide accurate diagnostic, and accurate therapeutic solutions. The transcranial neuroendoscopy segment is the fastest emerging segment growing at a high single digit CAGR during the forecasted period due to the ever-escalating prevalence of anterior skull base region associated diseases, increasing popularity of transcranial neuroendoscopy procedures across the globe, and the increasing research focus for the development of more efficient, and safer transcranial neuroendoscopy products. The urological endoscopy market is further categorized into Nephroscopy, Cystoscopy, ureteroscopy, and resectoscopy procedures. Among these, the ureteroscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the constantly elevating prevalence of chronic diseases associated with ureters, and kidney, increasing utilization of ureteroscopy to provide unerring diagnostic, and therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of ureteroscopy, and the increasing research focus for the development of more efficient, and safer ureteroscopy products. Laparoscopic procedures are further classified into laparoscopic bariatric surgery, cholecystectomy, appendectomy, hernia repair, and hand-assisted laparoscopic procedures. Among these, the laparoscopic cholecystectomy segment accounted for the largest revenue in 2021, and is expected to grow at a double digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of gall bladder disorders, and increasing adoption of laparoscopic cholecystectomy to provide explicit diagnostic, and therapeutic solutions. The laparoscopic bariatric surgery segment is the fastest emerging segment growing at a double digit CAGR during the forecasted period due to the ever-escalating prevalence of obesity across the globe, increasing popularity of laparoscopic bariatric surgery across the globe, and the increasing research focus for the development of more efficient, and safer laparoscopic bariatric surgery products.
Based on the end-users, the endoscopy devices global market has been segmented into Hospitals, Endoscopy Ambulatory surgery centers (EASCs), Endoscopy Diagnostic Centers, and others consisting of Academic or Research Institutes, and Office based Endoscopy (OBE) suites. Among the various end-users, the Hospitals segment is the largest, and fastest emerging end-user and is expected to grow at a high single digit CAGR during the forecasted period due to the increased utilization of advanced endoscopy products in these clinical settings, the presence of a large number of sophisticated hospitals in the developed nations, and the constantly increasing number of hospitals with advanced infrastructural facilities in the developing nations.
The endoscopy devices global market is divided into four major geographies namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (ROW). Among these, North America occupied the largest share in the 2021 endoscopy devices global market, and is expected to grow at a mid single digit CAGR during the forecasted period. Persistently elevating chronic disease patient burden in the region, and elevating demand for the early diagnosis, and treatment of these diseases, escalating geriatric population burdened with numerous kinds of chronic diseases in the region, the increasing inclination, and adoption of technologically advanced diagnostic procedures, and minimally invasive therapeutic procedures by the patients of the region, availability of well-developed healthcare infrastructural facilities in the region, presence of several major endoscopy device companies in the region, and their increasing R&D investments in the region for the development of innovative, efficient, and safer endoscopy products, and a conducive regulatory, and reimbursement scenario in the region promoting the adoption of single-use endoscopes in the region are some of the factors that are propelling the endoscopy devices market growth in the region. Asia-Pacific region is the fastest emerging region and is expected of growing at a high single digit CAGR from 2021 to 2028. Steadily escalating chronic disease patient population in the region, and increasing demand for the prompt diagnosis, and treatment of these diseases, elevating geriatric population crippled with numerous kinds of chronic diseases in the region, increasing awareness, and demand for technologically advanced diagnostic procedures, and minimally invasive therapeutic procedures by the patients of the region, developing healthcare infrastructural facilities in the region, medical tourism prospects of some of the countries in the region, presence of several major endoscopy device companies in the region, and their increasing R&D investments for the development of innovative, efficient, and safer endoscopy products, presence of several domestic companies in the region offering endoscopy products at competitive prices, growing economies, and improving reimbursement scenario of these regions are some of the factors that are boosting the endoscopy devices market in the region
The endoscopy devices global market is a competitive market with more than half of the market being occupied by the top six players. Some of the key players of the endoscopy devices market are Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), Stryker Corporation (U.S.), Karl Storz SE & Co KG (Germany), Johnson & Johnson (U.S.), and Medtronic PLC (Ireland), Arthrex Inc. (U.S.), B. Braun Melsungen AG (Germany), Fujifilm Holdings Corporation (Japan), Hoya Corporation (Japan), and other Arthrex Inc. (U.S.), B. Braun Melsungen AG (Germany), Fujifilm Holdings Corporation (Japan), Hoya Corporation (Japan), and others.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
As estimated by IQ4I analysis, the endoscopy devices global market is expected to reach $39,475.6 million by 2028 growing at a high single digit CAGR from 2021 to 2028 due to persistently escalating prevalence, and incidence of chronic diseases across the globe, and the need for early diagnostic, and therapeutic interventions, increasing inclination of patients towards the minimally invasive therapeutic procedures, gradual transition of endoscopy devices market towards single-use endoscopes, the emergence of technologically advanced endoscopy products, the trend of acquisitions, and collaborations in the endoscopy device industry, and the increasing awareness, and adoption of the highly beneficial endoscopic procedures across the emerging nations.
The endoscopy devices global market is categorized into various market segments based on the product, application, end-users, and geography. Based on the type of endoscopy products, the market is segmented into endoscopes, endoscopic instruments, and endoscopic accessories. Among these, the Endoscopic Instruments segment held the largest share in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the increasing popularity of image-guided endoscopic surveillance, diagnostic, and therapeutic procedures to reduce morbidity, and mortality associated with the highly prevalent chronic diseases across the globe, and the necessity of the various endoscopy instruments to ensure the efficiency, safety, and completeness of an endoscopy procedure. Endoscopes segment is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the escalating demand for timely, and precise minimally invasive or non-invasive diagnostic, and therapeutic procedures from the large chronic disease patient pool across the globe, various technological, and fabrication advancements in endoscopes that are constantly expanding their diagnostic, and therapeutic application spectrum. Based on the product type, endoscopes have been further segmented into flexible endoscopes, rigid endoscopes, robot-assisted endoscopes, and AI-enhanced endoscopes, and capsule endoscopes. Among these, the Rigid Endoscopes segment occupy a major share in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028 due to increased utilization of rigid endoscopes for performing the highly popular endoscopic diagnostic, and therapeutic procedures like laparoscopy, arthroscopy, ENT endoscopy, and neuroendoscopy procedures, and the potential of rigid endoscopes to offer the best resolution, optical amplification, and larger field of view to perform various endoscopic procedures efficiently, and safely. Robot-Assisted Endoscopes, and artificial intelligence (AI) powered endoscopes segment is expected to be the fastest emerging segment growing with a double digit CAGR from 2021 to 2028 due to the emergence of several Robot Assisted Endoscopes, and AI guided endoscopy systems in the market, and the promising potential of robot-assisted endoscopes, and AI-enhanced endoscopy systems to mitigate the labor intensity of endoscopic procedures, and increase the precision, and safety of endoscopic procedures. Endoscopic instruments are further grouped into endoscopic cameras, digital documentation systems, light sources, monitors, and display systems, video converters, and processors, fluid management systems, and other endoscopic instruments comprised of insufflators, endoscopic ultrasound probes, and processors. Among the various endoscopic instruments, the Monitors, and display systems segment occupies a major share of revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the increasing utilization of highly accurate, and real-time images or videos to arrive at the optimum or error-free diagnostic conclusions, and to provide better clarity of the complex anatomical details to improve the precision, task efficiency, and productivity of surgeons during endoscopic therapeutic procedures, availability of technologically advanced monitors, and display units, and increasing popularity of image-guided minimally invasive endoscopic diagnostic, and therapeutic interventions among the masses. The digital documentation systems segment is expected to be the fastest-growing segment growing with a high single digit CAGR from 2021 to 2028 due to the increasing recognition of the importance of endoscopic image documentation or recording process as an integral aspect of endoscopy procedures to ensure the quality, safety, productivity, completeness, and efficiency of endoscopic procedures, and the various guidelines of major endoscopic societies like European Society of Gastrointestinal Endoscopy (ESGE), and American Society of Gastrointestinal Endoscopy (ASGE) that recommend systematic photo recording or documentation of endoscopy procedures, the necessity of digitalized documents to address or satisfy the concerns of the insurance providers, legal institutions, patients, and hospital trusts, and need of digital documents to guide future therapeutic decisions, and persistent technological advancements in the digital documentation systems. Endoscopic accessories are further classified into product types like biopsy forceps, graspers, snares, Trocars, surgical dissectors, and other accessories like endoscopic ultrasound needles, light cables, cytology brushes, bite-blocks, cleaning brushes, needle holders, retractors, endoscopic caps, and hoods, endoscopy masks. Among the various endoscopic accessories, the trocars segment occupy the largest share of revenue in 2021, and is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the necessity of the channel created by a trocar for the safer advancement or passage of endoscopes, and other equipment to internal body cavities through the smaller incisions with low insertion force, and without tearing, scarring or ripping off the surrounding fragile tissues or organs during endoscopy procedures.
The global endoscopy devices market based on applications has been classified into Arthroscopy, Pulmonary endoscopy, Laparoscopy, ENT endoscopy, Gastrointestinal endoscopy, Gynecology or obstetrics endoscopy, Neuroendoscopy, Urological endoscopy, and other Endoscopic applications consisting of cardiopulmonary endoscopy, dental endoscopy, ophthalmology endoscopy, and breast endoscopy. Among these, the Gastrointestinal endoscopy segment occupied the largest market share in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the persistently increasing prevalence of chronic diseases of the digestive tract, and the potential of gastrointestinal endoscopy to provide accurate diagnostic, and therapeutic solutions, increasing popularity of endoscopic surveillance as a preventive strategy for gastrointestinal cancer-associated morbidity, and mortality, and the ever-expanding diagnostic, and therapeutic application spectrum of gastrointestinal endoscopy procedures. The laparoscopy segment is the fastest emerging segment growing at a double digit CAGR from 2021 to 2028 due to the steadily escalating prevalence of chronic diseases of the digestive system, female reproductive system, and urinary tract system, and the potential of laparoscopy to provide accurate diagnostic, and therapeutic solutions, and the increasing research, and development activities leading to the emergence of numerous technologically advanced, patient-friendly, cosmetically advantageous laparoscopic procedures. The arthroscopy market is further segmented into knee arthroscopy, shoulder arthroscopy, wrist arthroscopy, ankle arthroscopy, elbow arthroscopy, hip arthroscopy, and other arthroscopy procedures consisting of spinal arthroscopy, and temporomandibular joint arthroscopy. Among these, the knee arthroscopy segment accounted for the largest revenue in 2021, and is expected to grow at a double digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of knee joint injuries especially related to sports, and increasing adoption of arthroscopy to provide premium diagnostic, and accurate therapeutic solutions. The hip arthroscopy segment is the fastest emerging segment growing at a double digit CAGR during the forecasted period due to the ever-escalating prevalence of hip injuries associated with sports or accidents, increasing popularity of hip arthroscopy procedures across the globe, and the increasing research focus for the development of more efficient, and safer hip arthroscopy products. The pulmonary endoscopy market is further classified into bronchoscopy, thoracoscopy, and mediastinoscopy. Among these, the bronchoscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the persistently escalating prevalence of chronic diseases of the lungs or bronchi, increasing utilization of bronchoscopy to provide premium diagnostic, and accurate therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of bronchoscopy, and the increasing research focus for the development of more efficient, and safer bronchoscopy products. The ENT endoscopy market is further categorized into nasal endoscopy, laryngoscopy, otoendoscopy, and transnasal endoscopy procedures. Among these, the nasal endoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the constantly escalating prevalence of chronic diseases associated with nasal cavity, and sinus passages, and increasing adoption of nasal endoscopy to provide optimum diagnostic, and therapeutic solutions. The laryngoscopy segment is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the ever elevating prevalence of chronic diseases associated with throat, larynx, and salivary gland, increasing popularity of laryngoscopy procedures across the globe, and the increasing research focus for the development of more efficient, and laryngoscopy products. The gastrointestinal endoscopy market is further segmented into Esophagogastroduodenoscopy, enteroscopy, colonoscopy, sigmoidoscopy, proctoscopy, and Cholangiopancreatoscopy procedures. Among these, the esophagogastroduodenoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR during the forecasted period due to the persistently escalating chronic diseases affecting the esophagus, stomach, duodenum, increasing adoption of esophagogastroduodenoscopy to provide optimized, and timely diagnostic, and therapeutic solutions, and the emergence of more efficient, and safer technologically advanced esophagogastroduodenoscopy products. The colonoscopy segment is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the ever-increasing prevalence of chronic diseases of the colon, and rectum, increasing adoption, and implementation of colonoscopic surveillance as a preventive strategy for colorectal cancer-associated morbidity, and mortality across the globe, and the increasing research focus for the development of more efficient, and colonoscopy products. The gynecological/obstetrics endoscopy market is further classified into Hysteroscopy, Colposcopy, Falloposcopy, and others comprised of amnioscopy, and fetoscopy procedures. Among these, the hysteroscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a mid single digit CAGR from 2021 to 2028 due to the steadily escalating prevalence of endocervical or intrauterine diseases, increasing utilization of hysteroscopy to provide precise diagnostic, and therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of hysteroscopy, and the increasing research focus for the development of more efficient, and safer hysteroscopy products. The neuroendoscopy market is further subdivided into epiduroscopy or spinal endoscopy, Intraventricular neuroendoscopy, Transcranial neuroendoscopy, and Transnasal neuroendoscopy procedures. Among these, the intraventricular neuroendoscopy segment accounted for the largest revenue in 2021, and is expected to grow at a mid single digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of ventricular system associated diseases, and increasing adoption of intraventricular neuroendoscopy to provide accurate diagnostic, and accurate therapeutic solutions. The transcranial neuroendoscopy segment is the fastest emerging segment growing at a high single digit CAGR during the forecasted period due to the ever-escalating prevalence of anterior skull base region associated diseases, increasing popularity of transcranial neuroendoscopy procedures across the globe, and the increasing research focus for the development of more efficient, and safer transcranial neuroendoscopy products. The urological endoscopy market is further categorized into Nephroscopy, Cystoscopy, ureteroscopy, and resectoscopy procedures. Among these, the ureteroscopy segment accounted for the largest revenue in 2021, and is the fastest emerging segment growing at a high single digit CAGR from 2021 to 2028 due to the constantly elevating prevalence of chronic diseases associated with ureters, and kidney, increasing utilization of ureteroscopy to provide unerring diagnostic, and therapeutic solutions, the ever-expanding diagnostic, and therapeutic spectrum of ureteroscopy, and the increasing research focus for the development of more efficient, and safer ureteroscopy products. Laparoscopic procedures are further classified into laparoscopic bariatric surgery, cholecystectomy, appendectomy, hernia repair, and hand-assisted laparoscopic procedures. Among these, the laparoscopic cholecystectomy segment accounted for the largest revenue in 2021, and is expected to grow at a double digit CAGR from 2021 to 2028 due to the persistently elevating prevalence of gall bladder disorders, and increasing adoption of laparoscopic cholecystectomy to provide explicit diagnostic, and therapeutic solutions. The laparoscopic bariatric surgery segment is the fastest emerging segment growing at a double digit CAGR during the forecasted period due to the ever-escalating prevalence of obesity across the globe, increasing popularity of laparoscopic bariatric surgery across the globe, and the increasing research focus for the development of more efficient, and safer laparoscopic bariatric surgery products.
Based on the end-users, the endoscopy devices global market has been segmented into Hospitals, Endoscopy Ambulatory surgery centers (EASCs), Endoscopy Diagnostic Centers, and others consisting of Academic or Research Institutes, and Office based Endoscopy (OBE) suites. Among the various end-users, the Hospitals segment is the largest, and fastest emerging end-user and is expected to grow at a high single digit CAGR during the forecasted period due to the increased utilization of advanced endoscopy products in these clinical settings, the presence of a large number of sophisticated hospitals in the developed nations, and the constantly increasing number of hospitals with advanced infrastructural facilities in the developing nations.
The endoscopy devices global market is divided into four major geographies namely, North America, Europe, Asia Pacific (APAC), and the Rest of the World (ROW). Among these, North America occupied the largest share in the 2021 endoscopy devices global market, and is expected to grow at a mid single digit CAGR during the forecasted period. Persistently elevating chronic disease patient burden in the region, and elevating demand for the early diagnosis, and treatment of these diseases, escalating geriatric population burdened with numerous kinds of chronic diseases in the region, the increasing inclination, and adoption of technologically advanced diagnostic procedures, and minimally invasive therapeutic procedures by the patients of the region, availability of well-developed healthcare infrastructural facilities in the region, presence of several major endoscopy device companies in the region, and their increasing R&D investments in the region for the development of innovative, efficient, and safer endoscopy products, and a conducive regulatory, and reimbursement scenario in the region promoting the adoption of single-use endoscopes in the region are some of the factors that are propelling the endoscopy devices market growth in the region. Asia-Pacific region is the fastest emerging region and is expected of growing at a high single digit CAGR from 2021 to 2028. Steadily escalating chronic disease patient population in the region, and increasing demand for the prompt diagnosis, and treatment of these diseases, elevating geriatric population crippled with numerous kinds of chronic diseases in the region, increasing awareness, and demand for technologically advanced diagnostic procedures, and minimally invasive therapeutic procedures by the patients of the region, developing healthcare infrastructural facilities in the region, medical tourism prospects of some of the countries in the region, presence of several major endoscopy device companies in the region, and their increasing R&D investments for the development of innovative, efficient, and safer endoscopy products, presence of several domestic companies in the region offering endoscopy products at competitive prices, growing economies, and improving reimbursement scenario of these regions are some of the factors that are boosting the endoscopy devices market in the region
The endoscopy devices global market is a competitive market with more than half of the market being occupied by the top six players. Some of the key players of the endoscopy devices market are Olympus Corporation (Japan), Boston Scientific Corporation (U.S.), Stryker Corporation (U.S.), Karl Storz SE & Co KG (Germany), Johnson & Johnson (U.S.), and Medtronic PLC (Ireland), Arthrex Inc. (U.S.), B. Braun Melsungen AG (Germany), Fujifilm Holdings Corporation (Japan), Hoya Corporation (Japan), and other Arthrex Inc. (U.S.), B. Braun Melsungen AG (Germany), Fujifilm Holdings Corporation (Japan), Hoya Corporation (Japan), and others.
The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
- North America
- U.S.
- Rest of North America
- Europe
- Germany
- France
- U.K.
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Rest of APAC
- Rest of the World (ROW)
- Brazil
- Rest of LATAM
- The Middle East and Others
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN, AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS, AND OPPORTUNITIES
3.3.1.1 Persistently escalating incidence, and prevalence of chronic diseases and the need for early diagnosis, and treatment
3.3.1.2 Increasing inclination towards minimally invasive therapeutic procedures
3.3.1.3 The gradual endoscopy market conversion from reusable to single-use endoscopes
3.3.1.4 The emergence of technologically advanced endoscopy products
3.3.1.5 Persistently elevating geriatric population with chronic diseases
3.3.1.6 Acquisitions and collaborations to open an array of opportunities for the market to flourish
3.3.1.7 Market expansion opportunities in emerging nations
3.3.2 RESTRAINTS, AND THREATS
3.3.2.1 High cost of the endoscopy devices, and procedures
3.3.2.2 Lack of skilled, and trained professionals
3.3.2.3 Increasing concerns about the adverse effects associated with endoscopic procedures
3.3.2.4 Stringent regulatory bodies guiding the endoscopy device manufacturers
3.3.2.5 The threat of non-invasive diagnostic, and therapeutic technologies
3.3.2.6 Unfavorable reimbursement scenario for the endoscopy procedures
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 13485 Medical Devices
3.4.1.3 ISO 10993 Biological Evaluation Of Medical Devices
3.4.2 THE U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 JAPAN
3.4.6 CHINA
3.4.7 INDIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT TABLE
3.6 TECHNOLOGICAL ADVANCEMENTS
3.6.1 THERAPEUTIC CAPSULE ENDOSCOPES WITH ACTIVE LOCOMOTION
3.6.2 MOLECULAR ENDOSCOPIC IMAGING (MEI)
3.6.3 VARIABLE STIFFNESS ENDOSCOPES, AND SHAPE LOCKING DEVICES OR OVERTUBES
3.6.4 MINIATURIZED ENDOSCOPES
3.6.5 3D ENDOSCOPES
3.6.6 NOTES, AND LESS
3.6.7 ADVANCED DIAGNOSTIC IMAGING TECHNIQUES
3.7 CLINICAL TRIALS
3.8 ENDOSCOPES – FDA, AND CE REGULATORY APPROVAL ANALYSIS
3.9 PATENT ANALYSIS
3.10 SINGLE-USE ENDOSCOPES MARKET
3.11 AUTOMATED ENDOSCOPE REPROCESSORS (AER) MARKET
3.12 REFURBISHED ENDOSCOPY DEVICES MARKET
3.13 PORTER’S FIVE FORCE ANALYSIS
3.13.1 THREAT OF NEW ENTRANTS
3.13.2 THREAT OF SUBSTITUTES
3.13.3 BARGAINING POWER OF SUPPLIERS
3.13.4 BARGAINING POWER OF BUYERS
3.13.5 COMPETITIVE RIVALRY
3.14 SUPPLY CHAIN ANALYSIS
3.15 AVERAGE SELLING PRICE (ASP) OF SELECT ENDOSCOPY DEVICES
3.16 IMPACT OF COVID-19 ON ENDOSCOPY DEVICES INDUSTRY
3.17 MARKET SHARE ANALYSIS
3.17.1 ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.2 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.3 PULMONARY ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.4 LAPARPOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.5 UROLOGICAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.6 ENT ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.7 GASTROINTESTINAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.8 GYNECOLOGY ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.9 NEUROENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.18 ENDOSCOPY DEVICES COMPANY COMPARISON TABLE BY REVENUE, PRODUCT, PRODUCT TYPE, AND APPLICATION
4 ENDOSCOPY DEVICES GLOBAL MARKET, BY APPLICATIONS
4.1 INTRODUCTION
4.2 ARTHROSCOPY
4.2.1 INTRODUCTION
4.2.2 KNEE ARTHROSCOPY
4.2.3 SHOULDER ARTHROSCOPY
4.2.4 WRIST ARTHROSCOPY
4.2.5 ANKLE ARTHROSCOPY
4.2.6 ELBOW ARTHROSCOPY
4.2.7 HIP ARTHROSCOPY
4.2.8 OTHER ARTHROSCOPY PROCEDURES
4.3 PULMONARY ENDOSCOPY
4.3.1 INTRODUCTION
4.3.2 BRONCHOSCOPY
4.3.3 THORACOSCOPY
4.3.4 MEDIASTINOSCOPY
4.4 ENT ENDOSCOPY
4.4.1 INTRODUCTION
4.4.2 NASAL ENDOSCOPY
4.4.3 LARYNGOSCOPY
4.4.4 OTOENDOSCOPY
4.4.5 TRANSNASAL ENDOSCOPY
4.5 GASTROINTESTINAL ENDOSCOPY
4.5.1 INTRODUCTION
4.5.2 ESOPHAGOGASTRODUODENOSCOPY
4.5.3 ENTEROSCOPY
4.5.4 COLONOSCOPY
4.5.5 SIGMOIDOSCOPY
4.5.6 PROCTOSCOPY
4.5.7 CHOLANGIOPANCREATOSCOPY
4.6 GYNECOLOGY/OBSTETRICS
4.6.1 INTRODUCTION
4.6.2 HYSTEROSCOPY
4.6.3 COLPOSCOPY
4.6.4 FALLOPOSCOPY
4.6.5 OTHER GYNECOLOGY/OBSTETRICS ENDOSCOPY APPLICATIONS
4.7 NEUROENDOSCOPY
4.7.1 INTRODUCTION
4.7.2 EPIDUROSCOPY OR SPINAL ENDOSCOPY
4.7.3 INTRAVENTRICULAR NEUROENDOSCOPY
4.7.4 TRANSCRANIAL NEUROENDOSCOPY
4.7.5 TRANSNASAL NEUROENDOSCOPY
4.8 UROLOGICAL ENDOSCOPY
4.8.1 INTRODUCTION
4.8.2 NEPHROSCOPY
4.8.3 CYSTOSCOPY
4.8.4 URETEROSCOPY
4.8.5 RESECTOSCOPY
4.9 LAPAROSCOPY
4.9.1 INTRODUCTION
4.9.2 LAPAROSCOPIC BARIATRIC SURGERY
4.9.3 LAPAROSCOPIC CHOLECYSTECTOMY
4.9.4 LAPAROSCPIC APPENDECTOMY
4.9.5 LAPAROSCOPIC HERNIA REPAIR
4.9.6 HAND ASSISTED LAPAROSCOPY
4.10 OTHER ENDOSCOPY APPLICATIONS
5 ENDOSCOPY DEVICES GLOBAL MARKET, BY PRODUCTS
5.1 INTRODUCTION
5.2 ENDOSCOPES
5.2.1 RIGID ENDOSCOPES
5.2.2 FLEXIBLE ENDOSCOPES
5.2.3 ROBOT-ASSISTED ENDOSCOPES, AND AI ENHANCED ENDOSCOPES
5.2.4 CAPSULE ENDOSCOPES
5.3 ENDOSCOPIC INSTRUMENTS
5.3.1 INTRODUCTION
5.3.2 ENDOSCOPIC CAMERAS
5.3.3 DIGITAL DOCUMENTATION SYSTEMS
5.3.4 LIGHT SOURCES
5.3.5 MONITORS, AND DISPLAY SYSTEMS
5.3.6 VIDEO CONVERTERS, AND PROCESSORS
5.3.7 FLUID MANAGEMENT SYSTEMS
5.3.8 OTHER ENDOSCOPIC INSTRUMENTS (INSUFFLATORS, ULTRASOUND PROBES, AND PROCESSORS)
5.4 ENDOSCOPIC ACCESSORIES
5.4.1 BIOPSY FORCEPS
5.4.2 GRASPERS, AND RETRACTORS
5.4.3 SNARES
5.4.4 TROCARS
5.4.5 SURGICAL DISSECTORS
5.4.6 OTHER ENDOSCOPIC ACCESSORIES
6 ENDOSCOPY DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 ENDOSCOPY AMBULATORY SURGERY CENTERS (EASC) OR AMBULATORY ENDOSCOPY CENTERS (AEC)
6.4 ENDOSCOPY DIAGNOSTIC CENTERS
6.5 OTHER END-USERS (OFFICE BASED ENDOSCOPY (OBE) SUITES, AND ACADEMIC, AND RESEARCH INSTITUTES)
7 GLOBAL ENDOSCOPY PROCEDURAL VOLUME
7.1 ENDOSCOPY - NUMBER OF PROCEDURES BY REGION
7.1.1 GLOBAL ARTHROSCOPY PROCEDURAL VOLUME
7.1.2 GLOBAL GASTROINTESTINAL ENDOSCOPY PROCEDURAL VOLUME
7.1.3 GLOBAL COLONOSCOPY PROCEDURAL VOLUME
7.1.4 GLOBAL UROLOGICAL ENDOSCOPY PROCEDURAL VOLUME
7.1.5 GLOBAL LAPAROSCOPY PROCEDURAL VOLUME
7.1.6 GLOBAL ENT ENDOSCOPY ROCEDURAL VOLUME
7.1.7 GLOBAL PULMONARY ENDOSCOPY PROCEDURAL VOLUME
7.1.8 GLOBAL NEUROENDOSCOPY PROCEDURAL VOLUME
8 REGIONAL MARKET ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 REST OF NORTH AMERICA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 UNITED KINGDOM
8.3.4 REST OF EUROPE
8.4 ASIA-PACIFIC
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 REST OF ASIA-PACIFIC (APAC)
8.5 REST OF THE WORLD (ROW)
8.5.1 BRAZIL
8.5.2 REST OF LATAM
8.5.3 MIDDLE EAST & OTHERS
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 PRODUCT APPROVAL
9.3 PRODUCT LAUNCH
9.4 ACQUISITIONS
9.5 COLLABORATIONS
9.6 OTHER DEVELOPMENTS
10 MAJOR PLAYER PROFILES
10.1 ARTHREX, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 B. BRAUN MELSUNGEN AG
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 BOSTON SCIENTIFIC CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 FUJIFILM HOLDINGS CORPORATION
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 HOYA CORPORATION (PENTAX MEDICAL)
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 JOHNSON & JOHNSON
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 KARL STORZ SE & CO. KG
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 MEDTRONIC, PLC.
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 OLYMPUS CORPORATION
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 STRYKER CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
2.6.1 MARKET SIZE ESTIMATION
2.6.2 MARKET BREAKDOWN, AND DATA TRIANGULATION
2.6.3 SECONDARY SOURCES
2.6.4 PRIMARY SOURCES
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.6.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS, AND OPPORTUNITIES
3.3.1.1 Persistently escalating incidence, and prevalence of chronic diseases and the need for early diagnosis, and treatment
3.3.1.2 Increasing inclination towards minimally invasive therapeutic procedures
3.3.1.3 The gradual endoscopy market conversion from reusable to single-use endoscopes
3.3.1.4 The emergence of technologically advanced endoscopy products
3.3.1.5 Persistently elevating geriatric population with chronic diseases
3.3.1.6 Acquisitions and collaborations to open an array of opportunities for the market to flourish
3.3.1.7 Market expansion opportunities in emerging nations
3.3.2 RESTRAINTS, AND THREATS
3.3.2.1 High cost of the endoscopy devices, and procedures
3.3.2.2 Lack of skilled, and trained professionals
3.3.2.3 Increasing concerns about the adverse effects associated with endoscopic procedures
3.3.2.4 Stringent regulatory bodies guiding the endoscopy device manufacturers
3.3.2.5 The threat of non-invasive diagnostic, and therapeutic technologies
3.3.2.6 Unfavorable reimbursement scenario for the endoscopy procedures
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 Quality Management System
3.4.1.2 ISO 13485 Medical Devices
3.4.1.3 ISO 10993 Biological Evaluation Of Medical Devices
3.4.2 THE U.S.
3.4.3 CANADA
3.4.4 EUROPE
3.4.5 JAPAN
3.4.6 CHINA
3.4.7 INDIA
3.5 REIMBURSEMENT SCENARIO
3.5.1 REIMBURSEMENT TABLE
3.6 TECHNOLOGICAL ADVANCEMENTS
3.6.1 THERAPEUTIC CAPSULE ENDOSCOPES WITH ACTIVE LOCOMOTION
3.6.2 MOLECULAR ENDOSCOPIC IMAGING (MEI)
3.6.3 VARIABLE STIFFNESS ENDOSCOPES, AND SHAPE LOCKING DEVICES OR OVERTUBES
3.6.4 MINIATURIZED ENDOSCOPES
3.6.5 3D ENDOSCOPES
3.6.6 NOTES, AND LESS
3.6.7 ADVANCED DIAGNOSTIC IMAGING TECHNIQUES
3.7 CLINICAL TRIALS
3.8 ENDOSCOPES – FDA, AND CE REGULATORY APPROVAL ANALYSIS
3.9 PATENT ANALYSIS
3.10 SINGLE-USE ENDOSCOPES MARKET
3.11 AUTOMATED ENDOSCOPE REPROCESSORS (AER) MARKET
3.12 REFURBISHED ENDOSCOPY DEVICES MARKET
3.13 PORTER’S FIVE FORCE ANALYSIS
3.13.1 THREAT OF NEW ENTRANTS
3.13.2 THREAT OF SUBSTITUTES
3.13.3 BARGAINING POWER OF SUPPLIERS
3.13.4 BARGAINING POWER OF BUYERS
3.13.5 COMPETITIVE RIVALRY
3.14 SUPPLY CHAIN ANALYSIS
3.15 AVERAGE SELLING PRICE (ASP) OF SELECT ENDOSCOPY DEVICES
3.16 IMPACT OF COVID-19 ON ENDOSCOPY DEVICES INDUSTRY
3.17 MARKET SHARE ANALYSIS
3.17.1 ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.2 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.3 PULMONARY ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.4 LAPARPOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.5 UROLOGICAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.6 ENT ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.7 GASTROINTESTINAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.8 GYNECOLOGY ENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.17.9 NEUROENDOSCOPY DEVICES GLOBAL MARKET SHARE BY KEY PLAYERS (2021)
3.18 ENDOSCOPY DEVICES COMPANY COMPARISON TABLE BY REVENUE, PRODUCT, PRODUCT TYPE, AND APPLICATION
4 ENDOSCOPY DEVICES GLOBAL MARKET, BY APPLICATIONS
4.1 INTRODUCTION
4.2 ARTHROSCOPY
4.2.1 INTRODUCTION
4.2.2 KNEE ARTHROSCOPY
4.2.3 SHOULDER ARTHROSCOPY
4.2.4 WRIST ARTHROSCOPY
4.2.5 ANKLE ARTHROSCOPY
4.2.6 ELBOW ARTHROSCOPY
4.2.7 HIP ARTHROSCOPY
4.2.8 OTHER ARTHROSCOPY PROCEDURES
4.3 PULMONARY ENDOSCOPY
4.3.1 INTRODUCTION
4.3.2 BRONCHOSCOPY
4.3.3 THORACOSCOPY
4.3.4 MEDIASTINOSCOPY
4.4 ENT ENDOSCOPY
4.4.1 INTRODUCTION
4.4.2 NASAL ENDOSCOPY
4.4.3 LARYNGOSCOPY
4.4.4 OTOENDOSCOPY
4.4.5 TRANSNASAL ENDOSCOPY
4.5 GASTROINTESTINAL ENDOSCOPY
4.5.1 INTRODUCTION
4.5.2 ESOPHAGOGASTRODUODENOSCOPY
4.5.3 ENTEROSCOPY
4.5.4 COLONOSCOPY
4.5.5 SIGMOIDOSCOPY
4.5.6 PROCTOSCOPY
4.5.7 CHOLANGIOPANCREATOSCOPY
4.6 GYNECOLOGY/OBSTETRICS
4.6.1 INTRODUCTION
4.6.2 HYSTEROSCOPY
4.6.3 COLPOSCOPY
4.6.4 FALLOPOSCOPY
4.6.5 OTHER GYNECOLOGY/OBSTETRICS ENDOSCOPY APPLICATIONS
4.7 NEUROENDOSCOPY
4.7.1 INTRODUCTION
4.7.2 EPIDUROSCOPY OR SPINAL ENDOSCOPY
4.7.3 INTRAVENTRICULAR NEUROENDOSCOPY
4.7.4 TRANSCRANIAL NEUROENDOSCOPY
4.7.5 TRANSNASAL NEUROENDOSCOPY
4.8 UROLOGICAL ENDOSCOPY
4.8.1 INTRODUCTION
4.8.2 NEPHROSCOPY
4.8.3 CYSTOSCOPY
4.8.4 URETEROSCOPY
4.8.5 RESECTOSCOPY
4.9 LAPAROSCOPY
4.9.1 INTRODUCTION
4.9.2 LAPAROSCOPIC BARIATRIC SURGERY
4.9.3 LAPAROSCOPIC CHOLECYSTECTOMY
4.9.4 LAPAROSCPIC APPENDECTOMY
4.9.5 LAPAROSCOPIC HERNIA REPAIR
4.9.6 HAND ASSISTED LAPAROSCOPY
4.10 OTHER ENDOSCOPY APPLICATIONS
5 ENDOSCOPY DEVICES GLOBAL MARKET, BY PRODUCTS
5.1 INTRODUCTION
5.2 ENDOSCOPES
5.2.1 RIGID ENDOSCOPES
5.2.2 FLEXIBLE ENDOSCOPES
5.2.3 ROBOT-ASSISTED ENDOSCOPES, AND AI ENHANCED ENDOSCOPES
5.2.4 CAPSULE ENDOSCOPES
5.3 ENDOSCOPIC INSTRUMENTS
5.3.1 INTRODUCTION
5.3.2 ENDOSCOPIC CAMERAS
5.3.3 DIGITAL DOCUMENTATION SYSTEMS
5.3.4 LIGHT SOURCES
5.3.5 MONITORS, AND DISPLAY SYSTEMS
5.3.6 VIDEO CONVERTERS, AND PROCESSORS
5.3.7 FLUID MANAGEMENT SYSTEMS
5.3.8 OTHER ENDOSCOPIC INSTRUMENTS (INSUFFLATORS, ULTRASOUND PROBES, AND PROCESSORS)
5.4 ENDOSCOPIC ACCESSORIES
5.4.1 BIOPSY FORCEPS
5.4.2 GRASPERS, AND RETRACTORS
5.4.3 SNARES
5.4.4 TROCARS
5.4.5 SURGICAL DISSECTORS
5.4.6 OTHER ENDOSCOPIC ACCESSORIES
6 ENDOSCOPY DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 ENDOSCOPY AMBULATORY SURGERY CENTERS (EASC) OR AMBULATORY ENDOSCOPY CENTERS (AEC)
6.4 ENDOSCOPY DIAGNOSTIC CENTERS
6.5 OTHER END-USERS (OFFICE BASED ENDOSCOPY (OBE) SUITES, AND ACADEMIC, AND RESEARCH INSTITUTES)
7 GLOBAL ENDOSCOPY PROCEDURAL VOLUME
7.1 ENDOSCOPY - NUMBER OF PROCEDURES BY REGION
7.1.1 GLOBAL ARTHROSCOPY PROCEDURAL VOLUME
7.1.2 GLOBAL GASTROINTESTINAL ENDOSCOPY PROCEDURAL VOLUME
7.1.3 GLOBAL COLONOSCOPY PROCEDURAL VOLUME
7.1.4 GLOBAL UROLOGICAL ENDOSCOPY PROCEDURAL VOLUME
7.1.5 GLOBAL LAPAROSCOPY PROCEDURAL VOLUME
7.1.6 GLOBAL ENT ENDOSCOPY ROCEDURAL VOLUME
7.1.7 GLOBAL PULMONARY ENDOSCOPY PROCEDURAL VOLUME
7.1.8 GLOBAL NEUROENDOSCOPY PROCEDURAL VOLUME
8 REGIONAL MARKET ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.2.1 U.S.
8.2.2 REST OF NORTH AMERICA
8.3 EUROPE
8.3.1 GERMANY
8.3.2 FRANCE
8.3.3 UNITED KINGDOM
8.3.4 REST OF EUROPE
8.4 ASIA-PACIFIC
8.4.1 JAPAN
8.4.2 CHINA
8.4.3 INDIA
8.4.4 REST OF ASIA-PACIFIC (APAC)
8.5 REST OF THE WORLD (ROW)
8.5.1 BRAZIL
8.5.2 REST OF LATAM
8.5.3 MIDDLE EAST & OTHERS
9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 PRODUCT APPROVAL
9.3 PRODUCT LAUNCH
9.4 ACQUISITIONS
9.5 COLLABORATIONS
9.6 OTHER DEVELOPMENTS
10 MAJOR PLAYER PROFILES
10.1 ARTHREX, INC.
10.1.1 OVERVIEW
10.1.2 FINANCIALS
10.1.3 PRODUCT PORTFOLIO
10.1.4 KEY DEVELOPMENTS
10.1.5 BUSINESS STRATEGY
10.1.6 SWOT ANALYSIS
10.2 B. BRAUN MELSUNGEN AG
10.2.1 OVERVIEW
10.2.2 FINANCIALS
10.2.3 PRODUCT PORTFOLIO
10.2.4 KEY DEVELOPMENTS
10.2.5 BUSINESS STRATEGY
10.2.6 SWOT ANALYSIS
10.3 BOSTON SCIENTIFIC CORPORATION
10.3.1 OVERVIEW
10.3.2 FINANCIALS
10.3.3 PRODUCT PORTFOLIO
10.3.4 KEY DEVELOPMENTS
10.3.5 BUSINESS STRATEGY
10.3.6 SWOT ANALYSIS
10.4 FUJIFILM HOLDINGS CORPORATION
10.4.1 OVERVIEW
10.4.2 FINANCIALS
10.4.3 PRODUCT PORTFOLIO
10.4.4 KEY DEVELOPMENTS
10.4.5 BUSINESS STRATEGY
10.4.6 SWOT ANALYSIS
10.5 HOYA CORPORATION (PENTAX MEDICAL)
10.5.1 OVERVIEW
10.5.2 FINANCIALS
10.5.3 PRODUCT PORTFOLIO
10.5.4 KEY DEVELOPMENTS
10.5.5 BUSINESS STRATEGY
10.5.6 SWOT ANALYSIS
10.6 JOHNSON & JOHNSON
10.6.1 OVERVIEW
10.6.2 FINANCIALS
10.6.3 PRODUCT PORTFOLIO
10.6.4 KEY DEVELOPMENTS
10.6.5 BUSINESS STRATEGY
10.6.6 SWOT ANALYSIS
10.7 KARL STORZ SE & CO. KG
10.7.1 OVERVIEW
10.7.2 FINANCIALS
10.7.3 PRODUCT PORTFOLIO
10.7.4 KEY DEVELOPMENTS
10.7.5 BUSINESS STRATEGY
10.7.6 SWOT ANALYSIS
10.8 MEDTRONIC, PLC.
10.8.1 OVERVIEW
10.8.2 FINANCIALS
10.8.3 PRODUCT PORTFOLIO
10.8.4 KEY DEVELOPMENTS
10.8.5 BUSINESS STRATEGY
10.8.6 SWOT ANALYSIS
10.9 OLYMPUS CORPORATION
10.9.1 OVERVIEW
10.9.2 FINANCIALS
10.9.3 PRODUCT PORTFOLIO
10.9.4 KEY DEVELOPMENTS
10.9.5 BUSINESS STRATEGY
10.9.6 SWOT ANALYSIS
10.10 STRYKER CORPORATION
10.10.1 OVERVIEW
10.10.2 FINANCIALS
10.10.3 PRODUCT PORTFOLIO
10.10.4 KEY DEVELOPMENTS
10.10.5 BUSINESS STRATEGY
10.10.6 SWOT ANALYSIS
LIST OF TABLES
TABLE 1 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 2 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION (2020-2028) ($MN)
TABLE 3 ARTHROSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 4 ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
TABLE 5 KNEE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
TABLE 6 SHOULDER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 7 WRIST ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 8 ANKLE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 9 ELBOW ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 10 HIP ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 11 OTHER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 12 PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 13 PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 14 BRONCHOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 15 THORACOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 16 MEDIASTINOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 17 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 18 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 19 NASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 20 LARYNGOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 21 OTOENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 22 TRANSNASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 23 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 24 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 25 ESOPHAGOGASTRODUODENOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 26 ENTEROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 27 COLONOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 28 SIGMOIDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 29 PROCTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 30 CHOLANGIOPANCREATOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 31 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 32 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 33 HYSTEROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 34 COLPOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 35 FALLOPOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 36 OTHER GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 37 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 38 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 39 SPINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 40 INTRAVENTRICULAR NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 41 TRANSCRANIAL NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 42 TRANSNASAL NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 43 UROLOGICAL ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 44 UROLOGICAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 45 NEPHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 46 CYSTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 47 URETEROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 48 RESECTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 49 LAPAROSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 50 LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 51 LAPAROSCOPIC BARIATRIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 52 LAPAROSCOPIC CHOLECYSTECTOMY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 53 LAPAROSCOPIC APPENDECTOMY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 54 LAPAROSCOPIC HERNIA REPAIR GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 55 HAND ASSISTED LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 56 OTHER ENDOSCOPY APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 57 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 58 ENDOSCOPES GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 59 ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 60 RIGID ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 61 FLEXIBLE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 62 ROBOT-ASSISTED ENDOSCOPES, AND AI ENHANCED ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 63 CAPSULE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 64 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 65 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 66 ENDOSCOPIC CAMERAS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 67 DIGITAL DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 68 LIGHT SOURCES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 69 MONITORS, AND DISPLAY SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 70 VIDEO CONVERTERS, AND PROCESSORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 71 FLUID MANAGEMENT SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 72 OTHER ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 73 ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 74 ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 75 BIOPSY FORCEPS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 76 GRASPERS AND RETRACTORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 77 SNARES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 78 TROCARS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 79 SURGICAL DISSECTORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 80 OTHER ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 81 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 82 HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 83 ENDOSCOPY AMBULATORY SURGERY CENTERS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 84 ENDOSCOPY DIAGNOSTIC CENTRES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 85 OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 86 GLOBAL ARTHROSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 87 GLOBAL GASTROINTESTINAL ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 88 GLOBAL COLONOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028)(NO’S) (MN)
TABLE 89 GLOBAL UROLOGY ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 90 GLOBAL LAPAROSCOPY ROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 91 GLOBAL ENT ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 92 GLOBAL PULMONARY ENDOSCOPY ROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 93 GLOBAL NEUROENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 94 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 95 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY, (2020-2028) ($MN)
TABLE 96 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
TABLE 97 NORTH AMERICA ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 98 NORTH AMERICA LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 99 NORTH AMERICA PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 100 NORTH AMERICA ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 101 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 102 NORTH AMERICA GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 103 NORTH AMERICA NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 104 NORTH AMERICA UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 105 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 106 NORTH AMERICA ENDOSCOPES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 107 NORTH AMERICA ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 108 NORTH AMERICA ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 109 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 110 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY, (2020-2028) ($MN)
TABLE 111 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
TABLE 112 EUROPE ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 113 EUROPE LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 114 EUROPE PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 115 EUROPE ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 116 EUROPE UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 117 EUROPE NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 118 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 119 EUROPE GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 120 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 121 EUROPE ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 122 EUROPE ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 123 EUROPE ENDOSCOPIC ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 124 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 125 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
TABLE 126 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
TABLE 127 ASIA-PACIFIC ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 128 ASIA-PACIFIC LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 129 ASIA-PACIFIC PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 130 ASIA-PACIFIC ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 131 ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 132 ASIA-PACIFIC GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 133 ASIA-PACIFIC NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 134 ASIA-PACIFIC UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 135 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 136 ASIA-PACIFIC ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 137 ASIA-PACIFIC ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 138 ASIA-PACIFIC ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 139 ASIA-PACIFIC ENDOSCOPY MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 140 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
TABLE 141 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
TABLE 142 ROW ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 143 ROW LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 144 ROW PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 145 ROW ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 146 ROW UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 147 ROW NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 148 ROW GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 149 ROW GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 150 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 151 ROW ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 152 ROW ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 153 ROW ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 154 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 155 PRODUCT APPROVALS (2020-2021)
TABLE 156 PRODUCT LAUNCH (2020-2021)
TABLE 157 ACQUISITIONS (2020-2021)
TABLE 158 COLLABORATIONS, (2020-2021)
TABLE 159 OTHER DEVELOPMENTS (2020-2021)
TABLE 160 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, AND R&D EXPENSES (2018-2020) ($MN)
TABLE 161 B. BRAUN MELSUNGEN AG: TOTAL REVENUE BY SEGMENTS (2018-2020) ($MN)
TABLE 162 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 163 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q2) ($MN)
TABLE 164 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2019-2021) (Q2) ($MN)
TABLE 165 BOSTON SCIENTIFIC CORPORATION: MEDSURG TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q2) ($MN)
TABLE 166 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY (2019-2021) (Q2) ($MN)
TABLE 167 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, AND R&D EXPENSES (2019-2021) (Q1) ($MN)
TABLE 168 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q1) ($MN)
TABLE 169 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY REGION (2019-2021) (Q1) ($MN)
TABLE 170 HOYA CORPORATION: TOTAL REVENUE, AND R&D EXPENSES, (2019-2021) (Q1) ($MN)
TABLE 171 HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q1) ($MN)
TABLE 172 HOYA CORPORATION: LIFE CARE SEGMENT TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q1) ($MN)
TABLE 173 HOYA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q1) ($MN)
TABLE 174 JOHNSON & JOHNSON: TOTAL REVENUE, AND R&D EXPENSES (2019-2021) (Q2) ($MN)
TABLE 175 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q2) ($MN)
TABLE 176 JOHNSON & JOHNSON: MEDICAL DEVICES REVENUE, BY SUB-SEGMENTS (2019-2021) (Q2) ($MN)
TABLE 177 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY (2019-2021) (Q2) ($MN)
TABLE 178 MEDTRONIC PLC: TOTAL REVENUE, AND R&D EXPENSES (2019-2021) (Q1) ($MN)
TABLE 179 MEDTRONIC PLC : TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q1) ($MN)
TABLE 180 MEDTRONIC PLC : MEDICAL SURGICAL REVENUE, BY SUB-SEGMENTS (2019-2021) (Q1) ($MN)
TABLE 181 MEDTRONIC, PLC: NEUROSCIENCE REVENUE, BY SUB-SEGMENTS (2019-2021) (Q1) ($MN)
TABLE 182 MEDTRONIC PLC : TOTAL REVENUE, BY GEOGRAPHY (2019-2021) (Q1) ($MN)
TABLE 183 OLYMPUS CORPORATION: TOTAL REVENUE, AND R&D EXPENSES, (2019-2021) (Q1) ($MN)
TABLE 184 OLYMPUS CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q1) ($MN)
TABLE 185 OLYMPUS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q1) ($MN)
TABLE 186 STRYKER CORPORATION: TOTAL REVENUE, AND R&D EXPENSES, (2019-2021) (Q2) ($MN)
TABLE 187 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q2) ($MN)
TABLE 188 STRYKER CORPORATION: MEDSURG TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q2) ($MN)
TABLE 189 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q2) ($MN)
TABLE 1 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 2 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY APPLICATION (2020-2028) ($MN)
TABLE 3 ARTHROSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 4 ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
TABLE 5 KNEE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION, (2020-2028) ($MN)
TABLE 6 SHOULDER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 7 WRIST ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 8 ANKLE ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 9 ELBOW ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 10 HIP ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 11 OTHER ARTHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 12 PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 13 PULMONARY ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 14 BRONCHOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 15 THORACOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 16 MEDIASTINOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 17 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 18 ENT ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 19 NASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 20 LARYNGOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 21 OTOENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 22 TRANSNASAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 23 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 24 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 25 ESOPHAGOGASTRODUODENOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 26 ENTEROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 27 COLONOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 28 SIGMOIDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 29 PROCTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 30 CHOLANGIOPANCREATOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 31 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 32 GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 33 HYSTEROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 34 COLPOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 35 FALLOPOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 36 OTHER GYNECOLOGY/OBSTETRICS ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 37 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 38 NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 39 SPINAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 40 INTRAVENTRICULAR NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 41 TRANSCRANIAL NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 42 TRANSNASAL NEUROENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 43 UROLOGICAL ENDOSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 44 UROLOGICAL ENDOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 45 NEPHROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 46 CYSTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 47 URETEROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 48 RESECTOSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 49 LAPAROSCOPY GLOBAL MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 50 LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 51 LAPAROSCOPIC BARIATRIC SURGERY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 52 LAPAROSCOPIC CHOLECYSTECTOMY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 53 LAPAROSCOPIC APPENDECTOMY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 54 LAPAROSCOPIC HERNIA REPAIR GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 55 HAND ASSISTED LAPAROSCOPY GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 56 OTHER ENDOSCOPY APPLICATIONS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 57 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 58 ENDOSCOPES GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 59 ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 60 RIGID ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 61 FLEXIBLE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 62 ROBOT-ASSISTED ENDOSCOPES, AND AI ENHANCED ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 63 CAPSULE ENDOSCOPES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 64 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 65 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 66 ENDOSCOPIC CAMERAS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 67 DIGITAL DOCUMENTATION SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 68 LIGHT SOURCES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 69 MONITORS, AND DISPLAY SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 70 VIDEO CONVERTERS, AND PROCESSORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 71 FLUID MANAGEMENT SYSTEMS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 72 OTHER ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 73 ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 74 ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 75 BIOPSY FORCEPS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 76 GRASPERS AND RETRACTORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 77 SNARES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 78 TROCARS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 79 SURGICAL DISSECTORS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 80 OTHER ENDOSCOPIC ACCESSORIES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 81 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 82 HOSPITALS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 83 ENDOSCOPY AMBULATORY SURGERY CENTERS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 84 ENDOSCOPY DIAGNOSTIC CENTRES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 85 OTHER END-USERS GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 86 GLOBAL ARTHROSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 87 GLOBAL GASTROINTESTINAL ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 88 GLOBAL COLONOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028)(NO’S) (MN)
TABLE 89 GLOBAL UROLOGY ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 90 GLOBAL LAPAROSCOPY ROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 91 GLOBAL ENT ENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 92 GLOBAL PULMONARY ENDOSCOPY ROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 93 GLOBAL NEUROENDOSCOPY PROCEDURAL VOLUME, BY REGION (2020-2028) (NO’S) (MN)
TABLE 94 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
TABLE 95 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY, (2020-2028) ($MN)
TABLE 96 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
TABLE 97 NORTH AMERICA ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 98 NORTH AMERICA LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 99 NORTH AMERICA PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 100 NORTH AMERICA ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 101 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 102 NORTH AMERICA GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 103 NORTH AMERICA NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 104 NORTH AMERICA UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 105 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 106 NORTH AMERICA ENDOSCOPES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 107 NORTH AMERICA ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 108 NORTH AMERICA ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 109 NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 110 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY, (2020-2028) ($MN)
TABLE 111 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
TABLE 112 EUROPE ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 113 EUROPE LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 114 EUROPE PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 115 EUROPE ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 116 EUROPE UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 117 EUROPE NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 118 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 119 EUROPE GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 120 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 121 EUROPE ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 122 EUROPE ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 123 EUROPE ENDOSCOPIC ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 124 EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 125 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
TABLE 126 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
TABLE 127 ASIA-PACIFIC ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 128 ASIA-PACIFIC LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 129 ASIA-PACIFIC PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 130 ASIA-PACIFIC ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 131 ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 132 ASIA-PACIFIC GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 133 ASIA-PACIFIC NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 134 ASIA-PACIFIC UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 135 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 136 ASIA-PACIFIC ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 137 ASIA-PACIFIC ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 138 ASIA-PACIFIC ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 139 ASIA-PACIFIC ENDOSCOPY MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 140 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY COUNTRY (2020-2028) ($MN)
TABLE 141 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATIONS (2020-2028) ($MN)
TABLE 142 ROW ARTHROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 143 ROW LAPAROSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 144 ROW PULMONARY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 145 ROW ENT ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 146 ROW UROLOGICAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 147 ROW NEUROENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 148 ROW GASTROINTESTINAL ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 149 ROW GYNECOLOGY ENDOSCOPY MARKET REVENUE, BY ANATOMY (2020-2028) ($MN)
TABLE 150 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 151 ROW ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 152 ROW ENDOSCOPIC INSTRUMENTS MARKET REVENUE, BY PRODUCTS (2020-2028) ($MN)
TABLE 153 ROW ENDOSCOPY ACCESSORIES MARKET REVENUE, BY PRODUCT (2020-2028) ($MN)
TABLE 154 ROW ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2020-2028) ($MN)
TABLE 155 PRODUCT APPROVALS (2020-2021)
TABLE 156 PRODUCT LAUNCH (2020-2021)
TABLE 157 ACQUISITIONS (2020-2021)
TABLE 158 COLLABORATIONS, (2020-2021)
TABLE 159 OTHER DEVELOPMENTS (2020-2021)
TABLE 160 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, AND R&D EXPENSES (2018-2020) ($MN)
TABLE 161 B. BRAUN MELSUNGEN AG: TOTAL REVENUE BY SEGMENTS (2018-2020) ($MN)
TABLE 162 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY, (2018-2020) ($MN)
TABLE 163 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2019-2021) (Q2) ($MN)
TABLE 164 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY SEGMENTS, (2019-2021) (Q2) ($MN)
TABLE 165 BOSTON SCIENTIFIC CORPORATION: MEDSURG TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q2) ($MN)
TABLE 166 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE BY GEOGRAPHY (2019-2021) (Q2) ($MN)
TABLE 167 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, AND R&D EXPENSES (2019-2021) (Q1) ($MN)
TABLE 168 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q1) ($MN)
TABLE 169 FUJIFILM HOLDINGS CORPORATION: TOTAL REVENUE, BY REGION (2019-2021) (Q1) ($MN)
TABLE 170 HOYA CORPORATION: TOTAL REVENUE, AND R&D EXPENSES, (2019-2021) (Q1) ($MN)
TABLE 171 HOYA CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q1) ($MN)
TABLE 172 HOYA CORPORATION: LIFE CARE SEGMENT TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q1) ($MN)
TABLE 173 HOYA CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q1) ($MN)
TABLE 174 JOHNSON & JOHNSON: TOTAL REVENUE, AND R&D EXPENSES (2019-2021) (Q2) ($MN)
TABLE 175 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q2) ($MN)
TABLE 176 JOHNSON & JOHNSON: MEDICAL DEVICES REVENUE, BY SUB-SEGMENTS (2019-2021) (Q2) ($MN)
TABLE 177 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY (2019-2021) (Q2) ($MN)
TABLE 178 MEDTRONIC PLC: TOTAL REVENUE, AND R&D EXPENSES (2019-2021) (Q1) ($MN)
TABLE 179 MEDTRONIC PLC : TOTAL REVENUE, BY SEGMENTS (2019-2021) (Q1) ($MN)
TABLE 180 MEDTRONIC PLC : MEDICAL SURGICAL REVENUE, BY SUB-SEGMENTS (2019-2021) (Q1) ($MN)
TABLE 181 MEDTRONIC, PLC: NEUROSCIENCE REVENUE, BY SUB-SEGMENTS (2019-2021) (Q1) ($MN)
TABLE 182 MEDTRONIC PLC : TOTAL REVENUE, BY GEOGRAPHY (2019-2021) (Q1) ($MN)
TABLE 183 OLYMPUS CORPORATION: TOTAL REVENUE, AND R&D EXPENSES, (2019-2021) (Q1) ($MN)
TABLE 184 OLYMPUS CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q1) ($MN)
TABLE 185 OLYMPUS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q1) ($MN)
TABLE 186 STRYKER CORPORATION: TOTAL REVENUE, AND R&D EXPENSES, (2019-2021) (Q2) ($MN)
TABLE 187 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2019-2021) (Q2) ($MN)
TABLE 188 STRYKER CORPORATION: MEDSURG TOTAL REVENUE, BY SUB-SEGMENTS, (2019-2021) (Q2) ($MN)
TABLE 189 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2019-2021) (Q2) ($MN)
LIST OF FIGURES
FIGURE 1 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, AND MARKET SHARE, BY REGION (2020-2028) ($MN)
FIGURE 2 ENDOSCOPY DEVICES GLOBAL MARKET: RESEARCH APPROACH
FIGURE 3 ENDOSCOPY DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 ENDOSCOPY DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 ENDOSCOPY DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 ENDOSCOPY DEVICES GLOBAL MARKET: MARKET SEGMENTATION
FIGURE 7 ENDOSCOPY DEVICES GLOBAL MARKET: APPLICATION MARKET SEGMENTATION
FIGURE 8 MARKET DYNAMICS
FIGURE 9 ENDOSCOPY DEVICES CLINICAL TRIAL ANALYSIS
FIGURE 10 ENDOSCOPY DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2017-2021)
FIGURE 11 ENDOSCOPY DEVICES MARKET: PORTER’S ANALYSIS
FIGURE 12 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 13 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 14 PULMONARY ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 15 LAPAROSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 16 UROLOGICAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 17 ENT ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 18 GI ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 19 GYNECOLOGY ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 20 NEUROENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 21 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY APPLICATION (2021) (CAGR) (%)
FIGURE 22 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 23 HIP ARTHROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 24 PULMONARY ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 25 ENT ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY, (2021 VS 2028) (%)
FIGURE 26 NASAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 27 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 28 ENTEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 29 COLONOSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 30 SIGMOIDOSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 31 CHOLANGIOPANCREATOSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 32 GYNECOLOGY/OBSTETRICSENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 33 HYSTEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 34 NEUROENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 35 UROLOGICAL ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 36 URETEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 37 LAPAROSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 38 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 39 ENDOSCOPES GLOBAL MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 40 FLEXIBLE ENDOSCOPES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 41 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET SHARE, BY PRODUCT, (2021 VS 2028) (%)
FIGURE 42 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2021 VS 2028) (%)
FIGURE 43 MONITORS, AND DISPLAY UNITS GLOBAL MARKET REVENUE, BY REGION (2021 VS 2028) (%)
FIGURE 44 ENDOSCOPY ACCESSORIES GLOBAL MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 45 ENDOSCOPY ACCESSORIES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 46 BIOPSY FORCEPS GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 47 GRASPERS, AND RETRACTORS GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 48 SNARES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 49 OTHER ENDOSCOPIC ACCESSORIES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 50 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 51 GLOBAL ENDOSCOPY PROCEDURAL VOLUME (NO’S) (MN)
FIGURE 52 GLOBAL ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028) NO’S (MN)
FIGURE 53 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
FIGURE 54 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION & COUNTRY (2021) ($MN)
FIGURE 55 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY, (2021 VS 2028) (%)
FIGURE 56 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) & CAGR (%)
FIGURE 57 NORTH AMERICA ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 58 NORTH AMERICA LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 59 NORTH AMERICA PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 60 NORTH AMERICA ENT ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 61 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 62 NORTH AMERICA GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 63 NORTH AMERICA NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 64 NORTH AMERICA UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 65 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 66 NORTH AMERICA ENDOSCOPES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 67 NORTH AMERICA ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 68 NORTH AMERICA PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 69 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 70 NORTH AMERICA ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028), NO’S (MN)
FIGURE 71 U.S. ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 72 U.S. ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 73 U.S ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 74 REST OF NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 75 REST OF NORTH AMERICA ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 76 REST OF NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 77 EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY, (2021 VS 2028) (%)
FIGURE 78 EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) (CAGR) (%)
FIGURE 79 EUROPE ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 80 EUROPE LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 81 EUROPE PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 82 EUROPE ENT ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 83 EUROPE UROLOGICAL ENDOSCOPY MARKET SHARE BY ANATOMY (2021 VS 2028) (%)
FIGURE 84 EUROPE NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 85 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 86 EUROPE GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 87 EUROPE ENDOSCOPY DEVICES MARKET BY PRODUCTS, (2021 VS 2028) (%)
FIGURE 88 EUROPE ENDOSCOPES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 89 EUROPE ENDOSCOPY INSTRUMENTS MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 90 EUROPE ENDOSCOPIC ACCESSORIES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 91 EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 92 EUROPE ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028) NO’S, (MN)
FIGURE 93 GERMANY ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 94 GERMANY ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 95 GERMANY ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 96 FRANCE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 97 FRANCE ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 98 FRANCE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 99 U.K. ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 100 U.K. ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 101 U.K. ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 102 REST OF EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 103 REST OF EUROPE ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 104 REST OF EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 105 ASIA PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY (2021 VS 2028) (%)
FIGURE 106 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) (CAGR) (%)
FIGURE 107 ASIA-PACIFIC ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 108 ASIA-PACIFIC LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 109 ASIA-PACIFIC PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 110 ASIA-PACIFIC ENT ENDOSCOPY MARKETSHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 111 ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 112 ASIA-PACIFIC GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 113 ASIA-PACIFIC NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 114 ASIA-PACIFIC UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 115 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 116 ASIA-PACIFIC ENDOSCOPES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 117 ASIA-PACIFIC ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 118 ASIA-PACIFIC ENDOSCOPY ACCESSORIES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 119 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 120 ASIA PACIFIC ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028) NO’S (MN)
FIGURE 121 JAPAN ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 122 JAPAN ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 123 JAPAN ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 124 CHINA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 125 CHINA ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 126 CHINA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 127 INDIA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 128 INDIA ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 129 INDIA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 130 REST OF APAC ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 131 REST OF APAC ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 132 REST OF APAC ENDOSCOPY MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 133 ROW ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY (2020 VS 2028) (%)
FIGURE 134 ROW ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATIONS (2021) (CAGR) (%)
FIGURE 135 ROW ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 136 ROW LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 137 ROW PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 138 ROW ENT ENDOSCOPY DEVICES MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 139 ROW UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 140 ROW NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 141 ROW GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 142 ROW GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 143 ROW ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 144 ROW ENDOSCOPES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 145 ROW ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 146 ROW ENDOSCOPIC ACCESSORIES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 147 ROW ENDOSCOPY MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 148 ROW ENDOSCOPY PROCEDURE VOLUME (2021 VS 2028), NO’S (MN)
FIGURE 149 BRAZIL ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 150 BRAZIL ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 151 BRAZIL ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 152 REST OF LATAM ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 153 THE REST OF LATAM ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 154 REST OF LATAM ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028)($MN)
FIGURE 155 MIDDLE EAST & OTHERS ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 156 MIDDLE EAST & OTHERS ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 157 MIDDLE EAST & OTHERS ENDOSCOPY MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 158 KEY GROWTH STRATEGIES, (2020-2021)
FIGURE 159 SWOT: ARTHREX, INC.
FIGURE 160 SWOT: B. BRAUN MELSUNGEN AG
FIGURE 161 SWOT: BOSTON SCIENTIFIC CORPORATION
FIGURE 162 SWOT: FUJIFILM HOLDINGS CORPORATION
FIGURE 163 SWOT: HOYA CORPORATION (PENTAX MEDICAL)
FIGURE 164 SWOT: JOHNSON & JOHNSON
FIGURE 165 SWOT: KARL STORZ SE & CO. KG
FIGURE 166 SWOT: MEDTRONIC PLC
FIGURE 167 SWOT: OLYMPUS CORPORATION
FIGURE 168 SWOT: STRYKER CORPORATION
FIGURE 1 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, AND MARKET SHARE, BY REGION (2020-2028) ($MN)
FIGURE 2 ENDOSCOPY DEVICES GLOBAL MARKET: RESEARCH APPROACH
FIGURE 3 ENDOSCOPY DEVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 ENDOSCOPY DEVICES GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 ENDOSCOPY DEVICES MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 ENDOSCOPY DEVICES GLOBAL MARKET: MARKET SEGMENTATION
FIGURE 7 ENDOSCOPY DEVICES GLOBAL MARKET: APPLICATION MARKET SEGMENTATION
FIGURE 8 MARKET DYNAMICS
FIGURE 9 ENDOSCOPY DEVICES CLINICAL TRIAL ANALYSIS
FIGURE 10 ENDOSCOPY DEVICES MARKET: PATENT FILING BY MAJOR PLAYERS (2017-2021)
FIGURE 11 ENDOSCOPY DEVICES MARKET: PORTER’S ANALYSIS
FIGURE 12 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 13 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 14 PULMONARY ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 15 LAPAROSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 16 UROLOGICAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 17 ENT ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 18 GI ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 19 GYNECOLOGY ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 20 NEUROENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY KEY PLAYERS (2021) (%)
FIGURE 21 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY APPLICATION (2021) (CAGR) (%)
FIGURE 22 ARTHROSCOPY DEVICES GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 23 HIP ARTHROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 24 PULMONARY ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 25 ENT ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY, (2021 VS 2028) (%)
FIGURE 26 NASAL ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 27 GASTROINTESTINAL ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 28 ENTEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 29 COLONOSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 30 SIGMOIDOSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 31 CHOLANGIOPANCREATOSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 32 GYNECOLOGY/OBSTETRICSENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 33 HYSTEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 34 NEUROENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 35 UROLOGICAL ENDOSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 36 URETEROSCOPY GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 37 LAPAROSCOPY GLOBAL MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 38 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 39 ENDOSCOPES GLOBAL MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 40 FLEXIBLE ENDOSCOPES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 41 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET SHARE, BY PRODUCT, (2021 VS 2028) (%)
FIGURE 42 ENDOSCOPIC INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2021 VS 2028) (%)
FIGURE 43 MONITORS, AND DISPLAY UNITS GLOBAL MARKET REVENUE, BY REGION (2021 VS 2028) (%)
FIGURE 44 ENDOSCOPY ACCESSORIES GLOBAL MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 45 ENDOSCOPY ACCESSORIES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 46 BIOPSY FORCEPS GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 47 GRASPERS, AND RETRACTORS GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 48 SNARES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 49 OTHER ENDOSCOPIC ACCESSORIES GLOBAL MARKET SHARE, BY REGION (2021 VS 2028) (%)
FIGURE 50 ENDOSCOPY DEVICES GLOBAL MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 51 GLOBAL ENDOSCOPY PROCEDURAL VOLUME (NO’S) (MN)
FIGURE 52 GLOBAL ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028) NO’S (MN)
FIGURE 53 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION (2020-2028) ($MN)
FIGURE 54 ENDOSCOPY DEVICES GLOBAL MARKET REVENUE, BY REGION & COUNTRY (2021) ($MN)
FIGURE 55 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY, (2021 VS 2028) (%)
FIGURE 56 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) & CAGR (%)
FIGURE 57 NORTH AMERICA ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 58 NORTH AMERICA LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 59 NORTH AMERICA PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 60 NORTH AMERICA ENT ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 61 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 62 NORTH AMERICA GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 63 NORTH AMERICA NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 64 NORTH AMERICA UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 65 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 66 NORTH AMERICA ENDOSCOPES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 67 NORTH AMERICA ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 68 NORTH AMERICA PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 69 NORTH AMERICA ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 70 NORTH AMERICA ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028), NO’S (MN)
FIGURE 71 U.S. ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 72 U.S. ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 73 U.S ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 74 REST OF NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 75 REST OF NORTH AMERICA ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 76 REST OF NORTH AMERICA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 77 EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY, (2021 VS 2028) (%)
FIGURE 78 EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) (CAGR) (%)
FIGURE 79 EUROPE ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 80 EUROPE LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 81 EUROPE PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 82 EUROPE ENT ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 83 EUROPE UROLOGICAL ENDOSCOPY MARKET SHARE BY ANATOMY (2021 VS 2028) (%)
FIGURE 84 EUROPE NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 85 EUROPE GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 86 EUROPE GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 87 EUROPE ENDOSCOPY DEVICES MARKET BY PRODUCTS, (2021 VS 2028) (%)
FIGURE 88 EUROPE ENDOSCOPES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 89 EUROPE ENDOSCOPY INSTRUMENTS MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 90 EUROPE ENDOSCOPIC ACCESSORIES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 91 EUROPE ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 92 EUROPE ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028) NO’S, (MN)
FIGURE 93 GERMANY ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 94 GERMANY ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 95 GERMANY ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 96 FRANCE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 97 FRANCE ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 98 FRANCE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 99 U.K. ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 100 U.K. ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 101 U.K. ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 102 REST OF EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 103 REST OF EUROPE ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 104 REST OF EUROPE ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 105 ASIA PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY (2021 VS 2028) (%)
FIGURE 106 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATION (2021) (CAGR) (%)
FIGURE 107 ASIA-PACIFIC ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 108 ASIA-PACIFIC LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 109 ASIA-PACIFIC PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 110 ASIA-PACIFIC ENT ENDOSCOPY MARKETSHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 111 ASIA-PACIFIC GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 112 ASIA-PACIFIC GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 113 ASIA-PACIFIC NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 114 ASIA-PACIFIC UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 115 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 116 ASIA-PACIFIC ENDOSCOPES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 117 ASIA-PACIFIC ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 118 ASIA-PACIFIC ENDOSCOPY ACCESSORIES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 119 ASIA-PACIFIC ENDOSCOPY DEVICES MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 120 ASIA PACIFIC ENDOSCOPY PROCEDURE VOLUME, (2021 VS 2028) NO’S (MN)
FIGURE 121 JAPAN ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 122 JAPAN ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 123 JAPAN ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 124 CHINA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 125 CHINA ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 126 CHINA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 127 INDIA ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 128 INDIA ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 129 INDIA ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 130 REST OF APAC ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 131 REST OF APAC ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 132 REST OF APAC ENDOSCOPY MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 133 ROW ENDOSCOPY DEVICES MARKET SHARE, BY COUNTRY (2020 VS 2028) (%)
FIGURE 134 ROW ENDOSCOPY DEVICES MARKET SHARE, BY APPLICATIONS (2021) (CAGR) (%)
FIGURE 135 ROW ARTHROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 136 ROW LAPAROSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 137 ROW PULMONARY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 138 ROW ENT ENDOSCOPY DEVICES MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 139 ROW UROLOGICAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 140 ROW NEUROENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 141 ROW GASTROINTESTINAL ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 142 ROW GYNECOLOGY ENDOSCOPY MARKET SHARE, BY ANATOMY (2021 VS 2028) (%)
FIGURE 143 ROW ENDOSCOPY DEVICES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 144 ROW ENDOSCOPES MARKET SHARE, BY PRODUCTS (2021 VS 2028) (%)
FIGURE 145 ROW ENDOSCOPIC INSTRUMENTS MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 146 ROW ENDOSCOPIC ACCESSORIES MARKET SHARE, BY PRODUCT (2021 VS 2028) (%)
FIGURE 147 ROW ENDOSCOPY MARKET SHARE, BY END-USERS (2021 VS 2028) (%)
FIGURE 148 ROW ENDOSCOPY PROCEDURE VOLUME (2021 VS 2028), NO’S (MN)
FIGURE 149 BRAZIL ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 150 BRAZIL ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 151 BRAZIL ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 152 REST OF LATAM ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 153 THE REST OF LATAM ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 154 REST OF LATAM ENDOSCOPY DEVICES MARKET REVENUE, BY END-USERS (2021 VS 2028)($MN)
FIGURE 155 MIDDLE EAST & OTHERS ENDOSCOPY DEVICES MARKET REVENUE, BY APPLICATION (2021 VS 2028) ($MN)
FIGURE 156 MIDDLE EAST & OTHERS ENDOSCOPY DEVICES, AND ENDOSCOPES MARKET REVENUE, BY PRODUCTS (2021 VS 2028) ($MN)
FIGURE 157 MIDDLE EAST & OTHERS ENDOSCOPY MARKET REVENUE, BY END-USERS (2021 VS 2028) ($MN)
FIGURE 158 KEY GROWTH STRATEGIES, (2020-2021)
FIGURE 159 SWOT: ARTHREX, INC.
FIGURE 160 SWOT: B. BRAUN MELSUNGEN AG
FIGURE 161 SWOT: BOSTON SCIENTIFIC CORPORATION
FIGURE 162 SWOT: FUJIFILM HOLDINGS CORPORATION
FIGURE 163 SWOT: HOYA CORPORATION (PENTAX MEDICAL)
FIGURE 164 SWOT: JOHNSON & JOHNSON
FIGURE 165 SWOT: KARL STORZ SE & CO. KG
FIGURE 166 SWOT: MEDTRONIC PLC
FIGURE 167 SWOT: OLYMPUS CORPORATION
FIGURE 168 SWOT: STRYKER CORPORATION
